Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
  4. Volume 25, Issue 1
  5. Article
Volume 25, Issue 1
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Introduction

, commonly known as the Mexican prickly poppy, has been historically employed in traditional medicine for various ailments, including liver disorders. Given the rising prevalence of liver diseases, including cancer, investigating the potential efficacy of in promoting liver health is of paramount importance. This review aims to provide a comprehensive analysis of the existing literature on the hepatoprotective and anticancer properties of

Methodology

A systematic literature search was conducted across PubMed, Google Scholar, and relevant botanical and pharmacological databases. Studies from various sources, including experiments, animal models, and clinical trials, were included in the review. The search focused on articles published up to 2010-2023, encompassing research that explored the botanical characteristics, chemical composition, traditional uses, and pharmacological properties of , specifically emphasizing its impact on liver health and cancer.

Results

The review revealed a wealth of studies highlighting the diverse pharmacological properties of . The botanical composition includes compounds with antioxidant and anti-inflammatory potential, suggesting hepatoprotective effects. Studies using and models demonstrated promising outcomes regarding liver function improvement and inhibition of liver cancer cell proliferation. While some clinical studies supported the traditional uses of , further well-designed trials are warranted to establish its clinical efficacy.

Conclusion

In conclusion, shows promise as a natural agent for promoting liver health and combating liver cancer. Bioactive compounds with antioxidant and anti-inflammatory properties suggest potential hepatoprotective effects. However, translating these findings into clinical practice requires further rigorous investigation, including well-designed clinical trials. This review provides a foundation for future research efforts aimed at elucidating the full therapeutic potential of in liver health and cancer management.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/acamc/10.2174/0118715206307964240821051756
2025-01-01
2025-01-10

  • From This Site

    /content/journals/acamc/10.2174/0118715206307964240821051756
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. NajmiA. JavedS.A. Al BrattyM. AlhazmiH.A. Modern approaches in the discovery and development of plant-based natural products and their analogs as potential therapeutic agents.Molecules202227234910.3390/molecules2702034935056662
     [Google Scholar]
  2. LiX. SunR. LiuR. Natural products in licorice for the therapy of liver diseases: Progress and future opportunities.Pharmacol. Res.201914421022610.1016/j.phrs.2019.04.02531022523
     [Google Scholar]
  3. DaliuP. SantiniA. NovellinoE. A decade of nutraceutical patents: where are we now in 2018?Expert Opin. Ther. Pat.2018281287588210.1080/13543776.2018.155226030484340
     [Google Scholar]
  4. PathakR. GoelA. TripathiS.C. Medicinal property and ethnopharmacological activities of Argemone mexicana: an overview.Ann. Rom. Soc. Cell Biol.2021202116151641
     [Google Scholar]
  5. PlazasE. Avila MM.C. MuñozD.R. Cuca SL.E. Natural isoquinoline alkaloids: Pharmacological features and multi-target potential for complex diseases.Pharmacol. Res.202217710612610.1016/j.phrs.2022.10612635151857
     [Google Scholar]
  6. BrahmachariG. GoraiD. RoyR. Argemone mexicana: Chemical and pharmacological aspects.Rev. Bras. Farmacogn.201323355957510.1590/S0102‑695X2013005000021
     [Google Scholar]
  7. PriyaC.L. RaoK.V. Ethanobotanical and current ethanopharmacological aspects of Argemone mexicana Linn: an overview.Int. J. Pharm. Sci. Res.2012372143
     [Google Scholar]
  8. BhattacharjeeI. ChatterjeeS.K. ChatterjeeS. ChandraG. Antibacterial potentiality of Argemone mexicana solvent extracts against some pathogenic bacteria.Mem. Inst. Oswaldo Cruz2006101664564810.1590/S0074‑0276200600060001117072477
     [Google Scholar]
  9. DuttaS. HazraK. PariaD. GhosalS. DixitA.K. RaoM.M. Phyto pharmacognostical Evaluation of Argemone mexicana L. Seeds.J. Pharmacogn. Phytochem.20187615071513
     [Google Scholar]
  10. Loza-MüllerL.J.A. Laines-HidalgoJ.I. Monforte-GonzálezM. Vázquez-FlotaF. Alkaloid distribution in seeds of Argemone mexicana L.(Papaveraceae).J. Mex. Chem. Soc.202165450150610.29356/jmcs.v65i4.1574
     [Google Scholar]
  11. SinghS.K. PandeyV.D. SinghA. SinghC. Antibacterial activity of seed extracts of Argemone mexicana L. on some pathogenic bacterial strains.Afr. J. Biotechnol.200982470777081
     [Google Scholar]
  12. Martínez-DelgadoA.A. AndaJ. León-MoralesJ.M. Mateos-DíazJ.C. Gutiérrez-MoraA. Castañeda-NavaJ.J. Argemone species: Potential source of biofuel and high-value biological active compounds.Environ. Eng. Res.202227220061910.4491/eer.2020.619
     [Google Scholar]
  13. IbrahimH.A. UmarM.A. BelloB.A. AliyuA. AhmadA. Analgesic and anti-inflammatory studies on the roots Argemone mexicana Linn (Family: Papaveraceae).J Pharm Biol Sci20161139295
     [Google Scholar]
  14. GbessoG.H.F. GbessoF.K. AdoukonouR.C.F. AkabassiG.C. PadonouE.A. BriceA. TenteH. Traditional knowledge and uses of Argemone mexicana L. (Papaveraceae) in southern Benin.Ethnobot. Res. Appl.2021211110.32859/era.21.20.1‑11
     [Google Scholar]
  15. SaranS. PadaliaH. GaneshaiahK.N. OberaiK. SinghP. JhaA.K. ShivaR.K. VermaP.A. UniyalS. SenthilK.A. Indian Bioresource Information Network (IBIN).Remote Sensing of Northwest Himalayan EcosystemsSpringer2019251264
     [Google Scholar]
  16. NancyA. PraveenaA. Argemone mexicana : A boon to medicinal and pharmacological approaches in current scenario.Cardiovascul.Hematol. Agent Med. Chem.20171527890
     [Google Scholar]
  17. KrantiW. NiveditaG. MaheshS. JadhavR. Efficiency of phytochemicals obtained from selected invasive weeds against mustard aphid (Lipaphis Erysimi) Kalt. Res.Jr. Agril Sci.2023141242246
     [Google Scholar]
  18. ConwayS. Anatomy and Morphology of the Seed Coat in the Texas Species of Argemone.PhD Thesis, Texas State University, San Marcos, Texas, 2022.
     [Google Scholar]
  19. AbubakarA. DafamD.G. YakubuT.P. SanogoR. DialloD. AlemikaT. Pharmacognostic, physicochemical and phytochemical investigations on aerial parts of Argemone mexicana L.Res. J.Pharmacog2020731524
     [Google Scholar]
  20. OshoA. AdetunjiT. Antimicrobial activity of the essential oil of Argemone mexicana Linn.J. Med. Plants Res.2010411922
     [Google Scholar]
  21. ApuA.S. Al-BaizydA.H. AraF. BhuyanS.H. MatinM. HossainM.F. Phytochemical analysis and bioactivities of Argemone mexicana Linn. leaves.Pharmacologyonline201231623
     [Google Scholar]
  22. JaiswalJ. SiddiqiN.J. FatimaS. AbudawoodM. AlDaihanS.K. AlharbiM.G. de Lourdes PereiraM. SharmaP. SharmaB. Analysis of biochemical and antimicrobial properties of bioactive molecules of Argemone mexicana. Molecules20232811442810.3390/molecules2811442837298904
     [Google Scholar]
  23. ChaityF.R. RashidM.A. RahmanM.S. Biological investigations of the whole plant of Argemone mexicana (L.). dhaka university.J. Pharm. Sci.2021201135138
     [Google Scholar]
  24. LingarajuD.P. SudarshanaM.S. MahendraC. RaoK.P. Phytochemical screening and antimicrobial activity of leaf extracts of Eryngium foetidum L. (Apiaceae).Indo Am. J. Pharmaceut. Res.20166243394344
     [Google Scholar]
  25. AliS.A. ShariefN.H. MohamedY.S. Hepatoprotective activity of some medicinal plants in Sudan.Evid. Based Complement. Alternat. Med.2019201911610.1155/2019/219631531929810
     [Google Scholar]
  26. WarikooR. KumarS. Impact of Argemone mexicana extracts on the cidal, morphological, and behavioral response of dengue vector, Aedes aegypti L. (Diptera: Culicidae).Parasitol. Res.2013112103477348410.1007/s00436‑013‑3528‑723835923
     [Google Scholar]
  27. KhanA.M. BhadauriaS. Analysis of medicinally important phytocompounds from Argemone mexicana.J. King Saud Univ. Sci.20193141020102610.1016/j.jksus.2018.05.009
     [Google Scholar]
  28. GelbandH. ChenC.J. ChenW. FranceschiS. HallS.A. LondonW.T. McGlynnK.A. Liver CancerCancer: Disease Control PrioritiesWashington (DC)he International Bank for Reconstruction and Development / The World Bank2016
     [Google Scholar]
  29. SiaD. VillanuevaA. FriedmanS.L. LlovetJ.M. Liver cancer cell of origin, molecular class, and effects on patient prognosis.Gastroenterology2017152474576110.1053/j.gastro.2016.11.04828043904
     [Google Scholar]
  30. AnwanwanD. SinghS.K. SinghS. SaikamV. SinghR. Challenges in liver cancer and possible treatment approaches. Biochimica et Biophysica Acta (BBA)-.Rev. Can.202018731188314
     [Google Scholar]
  31. Reyna-MargaritaH.R. IraisC.M. Mario-AlbertoR.G. AgustinaR.M. Luis-BenjamínS.G. DavidP.E. Plant phenolics and lectins as vaccine adjuvants.Curr. Pharm. Biotechnol.201920151236124310.2174/138920102066619071611070531333121
     [Google Scholar]
  32. LiuC.Y. ChenK.F. ChenP.J. Treatment of liver cancer.Cold Spring Harb. Perspect. Med.201559a02153510.1101/cshperspect.a02153526187874
     [Google Scholar]
  33. AlqahtaniA. KhanZ. AlloghbiA. Said AhmedT.S. AshrafM. HammoudaD.M. Hepatocellular carcinoma: molecular mechanisms and targeted therapies.Medicina (Kaunas)201955952610.3390/medicina5509052631450841
     [Google Scholar]
  34. BlachierM. LeleuH. Peck-RadosavljevicM. VallaD.C. Roudot-ThoravalF. The burden of liver disease in Europe: A review of available epidemiological data.J. Hepatol.201358359360810.1016/j.jhep.2012.12.00523419824
     [Google Scholar]
  35. RahibL. SmithB.D. AizenbergR. RosenzweigA.B. FleshmanJ.M. MatrisianL.M. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.Cancer Res.201474112913292110.1158/0008‑5472.CAN‑14‑015524840647
     [Google Scholar]
  36. TerraultN.A. LokA.S.F. McMahonB.J. ChangK.M. HwangJ.P. JonasM.M. BrownR.S.Jr BzowejN.H. WongJ.B. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.Hepatology20186741560159910.1002/hep.2980029405329
     [Google Scholar]
  37. JohnsonP.J. BerhaneS. KagebayashiC. SatomuraS. TengM. ReevesH.L. O’BeirneJ. FoxR. SkowronskaA. PalmerD. YeoW. MoF. LaiP. IñarrairaeguiM. ChanS.L. SangroB. MiksadR. TadaT. KumadaT. ToyodaH. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.J. Clin. Oncol.201533655055810.1200/JCO.2014.57.915125512453
     [Google Scholar]
  38. SunE.J. WankellM. PalamuthusingamP. McFarlaneC. HebbardL. Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.Biomedicines2021911163910.3390/biomedicines911163934829868
     [Google Scholar]
  39. MintzK.J. LeblancR.M. The use of nanotechnology to combat liver cancer: Progress and perspectives.Biochim. Biophys. Acta Rev. Cancer20211876218862110.1016/j.bbcan.2021.18862134454983
     [Google Scholar]
  40. WangH. LinD. YuQ. LiZ. LenahanC. DongY. WeiQ. ShaoA. A promising future of ferroptosis in tumor therapy.Front. Cell Dev. Biol.2021962915010.3389/fcell.2021.62915034178977
     [Google Scholar]
  41. SaraswatV.A. PandeyG. ShettyS. Treatment algorithms for managing hepatocellular carcinoma.J. Clin. Exp. Hepatol.20144Suppl. 3S80S8910.1016/j.jceh.2014.05.00425755616
     [Google Scholar]
  42. CharrièreB. MaulatC. SucB. MuscariF. Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma.World J. Hepatol.201682188189010.4254/wjh.v8.i21.88127478538
     [Google Scholar]
  43. AllaireM. GoumardC. LimC. Le CleachA. WagnerM. ScattonO. New frontiers in liver resection for hepatocellular carcinoma.JHEP Reports20202410013410.1016/j.jhepr.2020.10013432695968
     [Google Scholar]
  44. GrandhiM.S. KimA.K. Ronnekleiv-KellyS.M. KamelI.R. GhasebehM.A. PawlikT.M. Hepatocellular carcinoma: From diagnosis to treatment.Surg. Oncol.2016252748510.1016/j.suronc.2016.03.00227312032
     [Google Scholar]
  45. LiuC. YangM. ZhangD. ChenM. ZhuD. Clinical cancer immunotherapy: Current progress and prospects.Front. Immunol.20221396180510.3389/fimmu.2022.96180536304470
     [Google Scholar]
  46. ShuelS.L. Targeted cancer therapies.Can. Fam. Physician202268751551810.46747/cfp.680751535831091
     [Google Scholar]
  47. MarshallA.C. Traditional Chinese medicine and clinical pharmacology.Springer International Publishing2020
     [Google Scholar]
  48. JemalA. CenterM.M. DeSantisC. WardE.M. Global patterns of cancer incidence and mortality rates and trends.Cancer Epidemiol. Biomarkers Prev.20101981893190710.1158/1055‑9965.EPI‑10‑043720647400
     [Google Scholar]
  49. SultanD.H. GhebrezadikD.G. SmithD.S. OmbengiD.N. AyedunL. LukeF.E. DemeryJ.L. ScogginsC.T. Penn-MarshallM. A problem in NIH and federally funded prostate cancer interventional clinical trials.J. Racial Ethn. Health Disparities202320231610.1007/s40615‑023‑01737‑937552424
     [Google Scholar]
  50. KaypeeS. SinghS. SwarnkarS. KunduTK. Emerging epigenetic therapies—lysine acetyltransferase inhibitors.Epigenetic Cancer TherapyAcademic Press2023pp. 459-505.
     [Google Scholar]
  51. SheenaB.S. HiebertL. HanH. IppolitoH. Abbasi-KangevariM. Abbasi-KangevariZ. AbbastabarH. AbdoliA. Abubaker AliH. AdaneM.M. AdegboyeO.A. AdnaniQ.E.S. AdvaniS.M. AfzalM.S. AfzalS. Aghaie MeybodiM. AhadinezhadB. AhinkorahB.O. AhmadS. AhmadT. AhmadiS. AhmedH. AhmedM.B. Ahmed RashidT. AkaluG.T. AkliluA. AkramT. Al HamadH. AlahdabF. AlemA.Z. AlemD.T. AlhalaiqaF.A.N. AlhassanR.K. AliL. AliM.A. AlimohamadiY. AlipourV. AlkhayyatM. AlmustanyirS. Al-RaddadiR.M. AltawalahH. AminiS. AmuH. AncuceanuR. AndreiC.L. AndreiT. AnoushiravaniA. AnsarA. AnyasodorA.E. ArablooJ. Arab-ZozaniM. ArgawA.M. ArgawZ.G. ArshadM. ArtamonovA.A. AshrafT. AtlawD. AusloosF. AusloosM. AzadnajafabadS. Azangou-KhyavyM. Azari JafariA. AzarianG. BagheriS. BahadoryS. BaigA.A. BanachM. BaratiN. BarrowA. BatihaA-M.M. Bejarano RamirezD.F. BelgaumiU.I. BerhieA.Y. BhagatD.S. BhardwajN. BhardwajP. BhattacharyyaK. BhojarajaV.S. BijaniA. BiondiA. BodichaB.B.A. BojiaH.A. BoloorA. BosettiC. BraithwaiteD. BrikoN.I. ButtZ.A. CámeraL.A. ChakinalaR.C. ChakrabortyP.A. CharanJ. ChenS. ChoiJ-Y.J. ChoudhariS.G. ChowdhuryF.R. ChuD-T. ChungS-C. CortesiP.A. CowieB.C. CulbrethG.T. DadrasO. DaiX. DandonaL. DandonaR. De la HozF.P. DebelaS.A. DedefoM.G. DemekeF.M. DemieT.G.G. DemissieG.D. Derbew MollaM. DestaA.A. DhamnetiyaD. DhimalM.L. DhimalM. DidehdarM. DoanL.P. DorostkarF. DrakeT.M. EghbalianF. EkholuenetaleM. El SayedI. El Sayed ZakiM. ElhadiM. ElmonemM.A. ElsharkawyA. EnanyS. EnyewD.B. ErkhembayarR. EskandariehS. EsmaeilzadehF. EzzikouriS. FarrokhpourH. FetensaG. FischerF. ForoutanM. GadM.M. GaidhaneA.M. GaidhaneS. GallesN.C. GallusS. GebremeskelT.G. GebreyohannesE.A. GhadiriK. GhaffariK. GhafourifardM. GhamariS-H. GhashghaeeA. GholamiA. GholizadehA. GilaniA. GoelA. GolechhaM. GoleijP. GolinelliD. GoriniG. GoshuY.A. GriswoldM.G. GubariM.I.M. GuptaB. GuptaS. GuptaV.B. GuptaV.K. HaddadiR. HalwaniR. HamidS.S. HamidiS. HanifA. HaqueS. HarapanH. HargonoA. HaririS. HasaballahA.I. HasanS.M.M. HassanipourS. HassankhaniH. HayS.I. HayatK. HeidariG. HerteliuC. HeyiD.Z. HezamK. HollaR. HosseiniM-S. HosseiniM. HosseinzadehM. HostiucM. HousehM. HuangJ. HusseinN.R. IavicoliI. IbitoyeS.E. IlesanmiO.S. IlicI.M. IlicM.D. IrhamL.M. IslamJ.Y. IsmailN.E. JacobsenK.H. Jadidi-NiaraghF. Javadi MamaghaniA. JayaramS. JayawardenaR. JebaiR. JhaR.P. JosephN. JoukarF. KaambwaB. KabirA. KabirZ. KalhorR. KandelH. KankoT.K.T. KantarR.S. KarayeI.M. KassaB.G. Kemp BohanP.M. KeykhaeiM. KhaderY.S. KhajuriaH. KhanG. KhanI.A. KhanJ. KhanM.A.B. KhanaliJ. KhaterA.M. KhatibM.N. KhodadostM. KhojaA.T. KhosravizadehO. KhubchandaniJ. KimG.R. KimH. KimM.S. KimY.J. KocarnikJ.M. KolahiA-A. KoteeswaranR. KumarG.A. La VecchiaC. LalD.K. LandiresI. LasradoS. LazarusJ.V. LeddaC. LeeD.W. LeeS. LeeY.Y. LeviM. LiJ. LimS.S. LoboS.W. LopukhovP.D. LoureiroJ.A. MacLachlanJ.H. Magdy Abd El RazekH. Magdy Abd El RazekM. MajeedA. MakkiA. MalekpourM-R. MalekzadehR. MalikA.A. Mansour-GhanaeiF. MansourniaM.A. Martins-MeloF.R. MatthewsP.C. MendozaW. MenezesR.G. MeretojaT.J. MershaA.G. MestrovicT. MillerT.R. MinhL.H.N. MiricaA. MirmoeeniS. MirrakhimovE.M. MisraS. MithraP. MoazenB. MohamadkhaniA. MohammadiM. MohammedS. MokaN. MokdadA.H. MoludiJ. MomtazmaneshS. MonastaL. MoradiG. MoradzadehM. MoradzadehR. MoragaP. MostafaviE. MubarikS. MuniyandiM. MurrayC.J.L. NaghaviM. NaimzadaM.D. Narasimha SwamyS. NattoZ.S. NayakB.P. NazariJ. NegoiI. NegruS.M. NejadghaderiS.A. Neupane KandelS. NguyenH.L.T. NgwaC.H. NiaziR.K. NnajiC.A. NoubiapJ.J. NowrooziA. Nuñez-SamudioV. OanceaB. OchirC. OdukoyaO.O. OhI-H. OlagunjuA.T. OlakundeB.O. Omar BaliA. OmerE. OtstavnovS.S. OumerB. PadubidriJ.R. PanaA. PandeyA. ParkE-C. Pashazadeh KanF. PatelU.K. PaudelU. PetcuI-R. PirachaZ.Z. PollokR.C.G. PostmaM.J. PourshamsA. PoustchiH. RabieeM. RabieeN. RafieiA. RafieiS. RaghuramP.M. RahmanM. RahmaniA.M. RahmawatyS. RajeshA. RanasingheP. RaoC.R. RaoS.J. RashidiM. RashidiM-M. RawafD.L. RawafS. RawassizadehR. RezaeiN. RezapourA. Rezazadeh-KhademS. RodriguezJ.A.B. RwegereraG.M. SabourS. SaddikB. SaebM.R. SaeedU. SahebkarA. Saif-Ur-RahmanK.M. SalahiS. SalimzadehH. SampathC. SamyA.M. SanabriaJ. SanmarchiF. Santric-MilicevicM.M. SarveazadA. SathianB. SawhneyM. SeiduA-A. SepanlouS.G. SeylaniA. ShahabiS. ShaikhM.A. ShakerE. ShakhmardanovM.Z. ShannawazM. ShenoyS.M. ShettyJ.K. ShettyP.H. ShibuyaK. ShinJ.I. ShobeiriP. SibhatM.M. SinghA.D. SinghJ.A. SinghS. SkryabinV.Y. SkryabinaA.A. SohrabpourA.A. SongS. TabaeianS.P. TadesseE.G. TaheriM. TampaM. TanK-K. TavakoliA. TbakhiA. TeferaB.N. Tehrani-BanihashemiA. TesfawH.M. ThaparR. ThavamaniA. TohidastS.A. TollosaD.N. TostiM.E. Tovani-PaloneM.R. TrainiE. TranM.T.N. TrihandiniI. TusaB.S. UllahI. VacanteM. Valadan TahbazS. ValdezP.R. VarthyaS.B. VoB. WaheedY. WeldesenbetA.B. WoldemariamM. XuS. Yahyazadeh JabbariS.H. YaseriM. YeshawY. YiğitV. YirdawB.W. YonemotoN. YuC. YunusaI. ZahirM. ZakiL. ZamaniM. ZamanianM. ZastrozhinM.S. VosT. WardJ.W. DiracM.A. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Gastroenterol. Hepatol.20227979682910.1016/S2468‑1253(22)00124‑835738290
     [Google Scholar]
  52. MorganE. ArnoldM. GiniA. LorenzoniV. CabasagC.J. LaversanneM. VignatJ. FerlayJ. MurphyN. BrayF. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut202372233834410.1136/gutjnl‑2022‑32773636604116
     [Google Scholar]
  53. KulshresthaS. GoelA. SiddiqiN.J. FatimaS. SharmaB. Cancer-Preventive Activity of Argemone mexicana Linn Leaves and Its Effect on TNF-α and NF-κB Signalling.Cancers (Basel)20231523565410.3390/cancers1523565438067358
     [Google Scholar]
  54. SinghR. SharmaP. SinghM. AroraS.K. The evaluation of in vitro toxicity of the protein (LL 4218) isolated from leaves of Argemone mexicana in human hepatoma-derived cell line (HepG2) using multiplexing approach.J. Nat. Pharmaceut.20112417910.4103/2229‑5119.92854
     [Google Scholar]
  55. VermaS.K. SinghS.K. AbhishekM. ShivsharanS. In vitro cytotoxicity of Argemone mexicana against different human cancer cell lines.Int. J. Chem. Environ. Pharm. Res.2010113739
     [Google Scholar]
  56. BorlakJ. ChouguleA. SinghP.K. How useful are clinical liver function tests in in vitro human hepatotoxicity assays?Toxicol. In Vitro201428578479510.1016/j.tiv.2014.03.00624685772
     [Google Scholar]
  57. AlamA. KhanA.A. Argemone mexicana L.: A weed with versatile medicinal and pharmacological applications.Ann. Phytomed.20209121822310.21276/ap.2020.9.1.29
     [Google Scholar]
  58. TatheP.G. DeshmukhA.S. A review on role of Indian medicinal plants in treatment of Icterus.Int. J. Sci. Res. Arch.20238244545610.30574/ijsra.2023.8.2.0278
     [Google Scholar]
  59. WaghmareK. GhayalN. ShindikarM. JadhavR. Evaluation of efficacy of phytochemicals from invasive weeds against Dolichos bean Aphid, Aphis craccivora Koch.Int. J. Ecol. Environ. Sci.202349651952410.55863/ijees.2023.2892
     [Google Scholar]
  60. MatadaB.S. PattanashettarR. YernaleN.G. A comprehensive review on the biological interest of quinoline and its derivatives.Bioorg. Med. Chem.20213211597310.1016/j.bmc.2020.11597333444846
     [Google Scholar]
  61. NeagM.A. MocanA. EcheverríaJ. PopR.M. BocsanC.I. CrişanG. BuzoianuA.D. Berberine: Botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders.Front. Pharmacol.2018955710.3389/fphar.2018.0055730186157
     [Google Scholar]
  62. DashG.K. MurthyP.N. Evaluation of Argemone mexicana Linn. Leaves for wound healing activity.J. Nat. Prod. Plant Resour.2011114656
     [Google Scholar]
  63. jiG. ShuklaS.K. DwivediP. SundaramS. PrakashR. Inhibitive effect of Argemone mexicana plant extract on acid corrosion of mild steel.Ind. Eng. Chem. Res.20115021119541195910.1021/ie201450d
     [Google Scholar]
  64. BhatS.H. ShrivastavaR. MallaM.Y. IqbalM. AnjumT. MirA.H. SharmaM. Hepatoprotective activity of Argemone mexicana Linn against toxic effects of carbon tetrachloride in rats.World J. Pharm. Res.20143340374048
     [Google Scholar]
  65. AdamS.I. IdrisI.A. AbdelgadirE.H. AhmedR.H. KamalE.E. Evaluation of the hepatoprotective activity of Argemone mexicana aerial Part Extracts on CCL_4 induced liver damage in wistar rats.Br. J. Pharmacol. Toxicol.201125251256
     [Google Scholar]
  66. MalikC. MohantyJ.P. PradhanS. SharmaC. Phytochemistry and pharmacology of Argemone mexicana Linn-An Indian medicinal plant. Res.J. Pharmacogn. Phytochem.2023152732
     [Google Scholar]
  67. GaliK. RamakrishnanG. KothaiR. JaykarB. In-vitro anti-cancer activity of methanolic extract of leaves of Argemone mexicana Linn.Int. J. Pharm. Tech. Res.2011313291333
     [Google Scholar]
  68. SakthivadivelM. ThilagavathyD. Larvicidal and chemosterilant activity of the acetone fraction of petroleum ether extract from Argemone mexicana L. seed.Bioresour. Technol.200389221321610.1016/S0960‑8524(03)00038‑512699943
     [Google Scholar]
  69. Leyva-PeraltaM.A. Robles-ZepedaR.E. Garibay-EscobarA. Ruiz-BustosE. Alvarez-BerberL.P. Gálvez-RuizJ.C. In vitro anti-proliferative activity of Argemone gracilenta and identification of some active components.BMC Complement. Altern. Med.20151511310.1186/s12906‑015‑0532‑825652581
     [Google Scholar]
  70. MiriamJ. SrimathiR. JayaramanG. In vitro and in vivo studies of Argemone mexicana linn. extracts against cobra venom (Naja naja) induced toxicity.Curr. Trend Biotechnol. Pharm.202216S118
     [Google Scholar]
  71. MengieA.T. ChekolA.E. TilahunM.Z. MekonnenA.M. ShumetY.Y. TesfawAddis, G. DagnawBaye, N. BogaleK.A. AdelaA.M. GobezieY.T. AyalewT.G. BerihunD.S. Evaluation of in vivo wound-healing and anti-inflammatory activities of solvent fractions of fruits of Argemone mexicana L. (Papaveraceae).Evid. Based Complement. Alternat. Med.2022202211710.1155/2022/615456036457593
     [Google Scholar]
  72. Al-TohamyR. AliS.S. Saad-AllahK. FareedM. AliA. El-BadryA. El-ZawawyN.A. WuJ. SunJ. MaoG.H. RupaniP.F. Phytochemical analysis and assessment of antioxidant and antimicrobial activities of some medicinal plant species from Egyptian flora.J. Appl. Biomed.201816428930010.1016/j.jab.2018.08.001
     [Google Scholar]
  73. PrabhakaranD. MiliseviMm. Rajeshka NNAA. Anticancer activity of Argemone mexicana L.(flowers) against human liver cancer (HEPG2) cell line.Asian J. Pharm. Clin. Res.2017101035135310.22159/ajpcr.2017.v10i10.20744
     [Google Scholar]
  74. DatkhileK.D. PatilS.R. PatilM.N. DurgawaleP.P. JagdaleN.J. DeshmukhV.N. Studies on phytoconstituents, in vitro antioxidant, antibacterial and cytotoxicity potential of Argemone mexicana Linn. (family: Papaveraceae).J. Nat. Sci. Biol. Med.202011198205
     [Google Scholar]
  75. SotoK.M. Pérez BuenoJ.J. Mendoza LópezM.L. Apátiga-CastroM. López-RomeroJ.M. MendozaS. Manzano-RamírezA. Antioxidants in traditional mexican medicine and their applications as antitumor treatments.Pharmaceuticals202316448210.3390/ph1604048237111239
     [Google Scholar]
  76. LiuC. YangS. WangK. BaoX. LiuY. ZhouS. LiuH. QiuY. WangT. YuH. Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma.Biomed. Pharmacother.201912010954310.1016/j.biopha.2019.10954331655311
     [Google Scholar]
  77. JuaidN. AminA. AbdallaA. ReeseK. AlamriZ. MoulayM. AbduS. MiledN. Anti-hepatocellular carcinoma biomolecules: molecular targets insights.Int. J. Mol. Sci.202122191077410.3390/ijms22191077434639131
     [Google Scholar]
  78. DuQ. MengX. WangS. A comprehensive review on the chemical properties, plant sources, pharmacological activities, pharmacokinetic and toxicological characteristics of tetrahydropalmatine.Front. Pharmacol.20221389007810.3389/fphar.2022.89007835559252
     [Google Scholar]
  79. RuiY. LiS. LuanF. LiD. LiuR. ZengN. Several alkaloids in Chinese herbal medicine protect acute kidney injury: focus on mechanism and target analysis.Oxid. Med. Cell. Longev.2022202211610.1155/2022/242780235602100
     [Google Scholar]
  80. YooE.S. ChooG.S. KimS.H. WooJ.S. KimH.J. ParkY.S. KimB.S. KimS.K. ParkB.K. ChoS.D. NamJ.S. ChoiC.S. CheJ.H. JungJ.Y. Antitumor and apoptosis-inducing effects of piperine on human melanoma cells.Anticancer Res.20193941883189210.21873/anticanres.1329630952729
     [Google Scholar]
  81. NB. ChandrashekarK.R. PrabhuA. RekhaP.D. Tetrandrine isolated from Cyclea peltata induces cytotoxicity and apoptosis through ROS and caspase pathways in breast and pancreatic cancer cells.In Vitro Cell. Dev. Biol. Anim.201955533134010.1007/s11626‑019‑00332‑930945115
     [Google Scholar]
  82. ZhangY. GotoM. OdaA. HsuP.L. GuoL.L. FuY.H. Morris-NatschkeS.L. HamelE. LeeK.H. HaoX.J. Antiproliferative aspidosperma-type monoterpenoid indole alkaloids from Bousigonia mekongensis inhibit tubulin polymerization.Molecules2019247125610.3390/molecules2407125630935100
     [Google Scholar]
  83. WangY. ZhangS. LiuJ. FangB. YaoJ. ChengB. Matrine inhibits the invasive and migratory properties of human hepatocellular carcinoma by regulating epithelial‑mesenchymal transition.Mol. Med. Rep.201818191191910.3892/mmr.2018.902329845189
     [Google Scholar]
  84. ZhouN. LiJ. LiT. ChenG. ZhangZ. SiZ. Matrine-induced apoptosis in Hep3B cells via the inhibition of MDM2.Mol. Med. Rep.201715144245010.3892/mmr.2016.599927959389
     [Google Scholar]
  85. WangX. FengY. WangN. CheungF. TanH.Y. ZhongS. LiC. KobayashiS. Chinese medicines induce cell death: the molecular and cellular mechanisms for cancer therapy.BioMed Res. Int.2014201411410.1155/2014/53034225379508
     [Google Scholar]
  86. LiM. ZhangM. ZhangZ. LiuN. HanX. LiuQ. DengW. LiaoC. Induction of apoptosis by berberine in hepatocellular carcinoma HepG2 cells via downregulation of NF-κB.Oncol. Res.201725223323910.3727/096504016X1474289104907328277195
     [Google Scholar]
  87. LiJ. LiO. KanM. ZhangM. ShaoD. PanY. ZhengH. ZhangX. ChenL. LiuS. Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinoma.Mol. Med. Rep.20151234572457710.3892/mmr.2015.392626081696
     [Google Scholar]
  88. ZhangP. WangQ. LinZ. YangP. DouK. ZhangR. Berberine inhibits growth of liver cancer cells by suppressing glutamine uptake.OncoTargets Ther.202012117511176310.2147/OTT.S23566732021249
     [Google Scholar]
  89. RaufA. Abu-IzneidT. KhalilA.A. ImranM. ShahZ.A. EmranT.B. MitraS. KhanZ. AlhumaydhiF.A. AljohaniA.S.M. KhanI. RahmanM.M. JeandetP. GondalT.A. Berberine as a potential anticancer agent: A comprehensive review.Molecules20212623736810.3390/molecules2623736834885950
     [Google Scholar]
  90. DuD. LiuC. QinM. ZhangX. XiT. YuanS. HaoH. XiongJ. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.Acta Pharm. Sin. B202212255858010.1016/j.apsb.2021.09.01935256934
     [Google Scholar]
  91. AlmatroodiS.A. AlsahliM.A. RahmaniA.H. Berberine: An important emphasis on its anticancer effects through modulation of various cell signaling pathways.Molecules20222718588910.3390/molecules2718588936144625
     [Google Scholar]
  92. Al-MaharikN. Isolation of naturally occurring novel isoflavonoids: an update.Nat. Prod. Rep.20193681156119510.1039/C8NP00069G30632588
     [Google Scholar]
  93. SinghS. VermaM. MalhotraM. PrakashS. SinghT.D. Cytotoxicity of alkaloids isolated from Argemone mexicana on SW480 human colon cancer cell line.Pharm. Biol.201654474074510.3109/13880209.2015.107333426439487
     [Google Scholar]
  94. UddinM.S. HossainM.F. MamunA.A. ShahM.A. HasanaS. BulbulI.J. SarwarM.S. MansouriR.A. AshrafG.M. RaufA. Abdel-DaimM.M. Bin-JumahM.N. Exploring the multimodal role of phytochemicals in the modulation of cellular signaling pathways to combat age-related neurodegeneration.Sci. Total Environ.202072513831310.1016/j.scitotenv.2020.13831332464743
     [Google Scholar]
  95. OuédraogoJ.C.W. DickoC. KiniF.B. Bonzi-CoulibalyY.L. DeyE.S. Enhanced extraction of flavonoids from Odontonema strictum leaves with antioxidant activity using supercritical carbon dioxide fluid combined with ethanol.J. Supercrit. Fluids2018131667110.1016/j.supflu.2017.08.017
     [Google Scholar]
  96. ZakariaK.N. AmidA. ZakariaZ. JamalP. IsmailA. Anti-proliferative activity of triterpenes isolated from Clinicanthus nutans on Hep-G2 liver cancer cells.Asian Pac. J. Cancer Prev.201920256356710.31557/APJCP.2019.20.2.56330803221
     [Google Scholar]
  97. KimG.H. KanS.Y. KangH. LeeS. KoH.M. KimJ.H. LimJ.H. Ursolic acid suppresses cholesterol biosynthesis and exerts anti-cancer effects in hepatocellular carcinoma cells.Int. J. Mol. Sci.20192019476710.3390/ijms2019476731561416
     [Google Scholar]
  98. DubeyNK. DwivedyAK. ChaudhariAK. DasS. Common toxic plants and their forensic significance.Natural Products and Drug DiscoveryElsevier2018pp. 349-374.
     [Google Scholar]
  99. NyirendaK.K. Toxicity potential of cyanogenic glycosides in edible plants.Med. Toxicol.2020202019
     [Google Scholar]
/content/journals/acamc/10.2174/0118715206307964240821051756
Loading
An In-depth Review on Argemone mexicana in the Management of Liver Health and Liver Cancer
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents) 25, 24 (2025); https://doi.org/10.2174/0118715206307964240821051756
/content/journals/acamc/10.2174/0118715206307964240821051756
/content/journals/acamc/10.2174/0118715206307964240821051756
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): anti-cancer; anti-inflammatory; antioxidant; hepatoprotective; liver diseases; Medicinal plants; phytochemical

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test